The success of Viagra initially drove a boom for pharma, but recent shifts present a complicated picture for those considering a stake. Off-patent versions are reducing revenue, and ongoing patent challenges add https://inesvwjf009393.blog-eye.com/41526540/the-blue-pill-and-pharma-a-risky-bet